Clinical Trials Details

Breast Cancer

A Phase III Clinical Trial Comparing Trastuzumab Given Concurently with Radiation and Radiation Alone for Women with Her2-Postive Ductal Carcinoma In Situ (DCIS) Resected by Lumpectomy

Trial ID: 09132

Contact: Denise L Elmore

Phone: (281)863-4609

Learn More about this trial.

go back | new search

This Study is currently being offered at the following Sites:

Practice	State/City
Texas Oncology, P.A.	Arlington, TX (South)
Rocky Mountain Cancer Centers, LLP	Aurora, CO
Texas Oncology, P.A.	Bedford, TX (Edwards CC)(RAD)
Texas Oncology, P.A.	Bedford, TX (Harris HEB)
Texas Oncology, P.A.	Denton, TX
Texas Oncology, P.A.	Fort Worth, TX (12th Ave.)
Texas Oncology, P.A.	Fort Worth, TX (8th) Rad Only
Texas Oncology, P.A.	Fort Worth, TX (Klabzuba) Rad
Central Indiana Cancer Centers	Indianapolis, IN (E. County)
Kansas City Cancer Center, LLC.	Kansas City, MO (North)
Texas Oncology, P.A.	Longview, TX
Texas Oncology, P.A.	Odessa, TX
Cancer Centers of Florida, P.A.	Orlando, FL (52 Gore) RT ONLY
Texas Oncology, P.A.	Sherman, TX
Cancer Care Northwest, P.S.	Spokane, WA (Sherman)
Texas Oncology, P.A.	Sugar Land, TX
Arizona Oncology Associates, PC - SRO	Tucson, AZ (Orange Grove Rd)
Arizona Oncology Associates, PC - HOPE	Tucson, AZ (Rudasill - HOPE)